Bayer

News

Bayer files prostate cancer drug darolutamide in Japan

Bayer has filed its prostate cancer drug darolutamide with Japanese regulators, in an attempt to ratchet up the pressure on rivals Johnson & Johnson and Pfizer/Astellas.

News

Bayer completes US filing for prostate cancer drug darolutam...

Bayer has completed its rolling marketing application for prostate cancer drug darolutamide in the US, setting up possible approval later this year and a market clash with Pfizer/Astellas a

News

Bayer takes control of Loxo duo as Lilly closes takeover

Bayer has acquired full rights to two drugs partnered with Loxo Oncology, on the same day that the biotech was taken over by Eli Lilly in an

News

Bayer/Orion showcase results from prostate cancer challenger

Bayer and development partner Orion have released detailed results from the trial that will form the backbone of its filing for their latest prostate cancer drug, as they aim to take on two

News

FDA breakthrough designation for Bayer and Merck & Co’s AI s...

Bayer and Merck & Co have won a breakthrough device designation from the US regulator FDA for artificial intelligence software they are jointly developing.

News

Bayer/Loxo drug approved in cancers with certain mutation

The FDA has approved Bayer and Loxo’s Vitrakvi (larotrectinib) for adults and children whose cancers have a specific genetic feature, or biomarker.

Bayer files prostate cancer drug darolutamide in Japan

Bayer completes US filing for prostate cancer drug darolutam...

Bayer takes control of Loxo duo as Lilly closes takeover

Bayer/Orion showcase results from prostate cancer challenger

FDA breakthrough designation for Bayer and Merck & Co’s AI s...

Bayer/Loxo drug approved in cancers with certain mutation

Dexcom is first to join FDA/CMS health tech pilot

Discover a new era of healthcare panel engagement: Grounded ...

Bayer

Editor's Picks